Obstructive sleep apnea (OSA) is thought to affect almost 1 billion people worldwide. OSA
has well established cardiovascular and neurocognitive sequelae, although the optimal …

Summary The publication of “The Sleep Apnea Syndromes” by Guilleminault et al. in the
1970s hallmarked the discovery of a new disease entity involving serious health …

Rationale: Data from population-based cohorts suggest that symptom subtypes and
obstructive sleep apnea (OSA)–specific hypoxic burden (HB) could help to better identify …

One‐seventh of the world's adult population, or approximately one billion people, are
estimated to have OSA. Over the past four decades, obesity, the main risk factor for OSA, has …

The prevalence of obstructive sleep apnea (OSA) continues to rise. So too do the health,
safety, and economic consequences. On an individual level, the causes and consequences …

Rationale: Symptom subtypes have been described in clinical and population samples of
patients with obstructive sleep apnea (OSA). It is unclear whether these subtypes have …

Identification of obstructive sleep apnea and risk factors is important for reduction in
symptoms and cardiovascular risk, and for improvement of quality of life. The population …

Importance Obstructive sleep apnea (OSA) is the most common clinically significant
breathing abnormality during sleep. It is highly prevalent among patients with atrial …

Objective To present 5-year outcomes from a prospective cohort of patients with obstructive
sleep apnea (OSA) who were treated with upper airway stimulation (UAS) via a unilateral …

Obstructive sleep apnoea (OSA) is a major challenge for physicians and healthcare systems
throughout the world. The high prevalence and the impact on daily life of OSA oblige …